Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease hyperparathyroidism
Symptom C0035078|renal failure
Sentences 24
PubMedID- 24795828 Hypercalcemia and hyperparathyroidism resulting from chronic renal failure cause soft tissue microcalcification .
PubMedID- 24959180 Cinacalcet (sensipar), a calcimimetic drug, is available for the treatment of secondary hyperparathyroidism associated with renal failure, hypercalcemia in parathyroid cancer, and the treatment of severe hypercalcemia in patients with primary hyperparathyroidism unable to undergo parathyroidectomy .
PubMedID- 21655171 hyperparathyroidism in renal failure is the result of retention of phosphate due to decreased glomerular filtration rate, with consequent hypocalcemia resulting in parathyroid gland stimulation.
PubMedID- 26134532 Comparison between subtotal parathyroidectomy and total parathyroidectomy with autotransplantation for secondary hyperparathyroidism in patients with chronic renal failure: a meta-analysis.
PubMedID- 25199318 Methods: seven adult patients who had undergone parathyroidectomy for secondary hyperparathyroidism associated with chronic renal failure were included in this study.
PubMedID- 20454761 Supra-acetabular brown tumor due to primary hyperparathyroidism associated with chronic renal failure.
PubMedID- 21876786 Hyperphosphatemia is a driving force in the pathogenesis of vascular calcification (vc) and secondary hyperparathyroidism associated with renal failure.
PubMedID- 25130159 Brown tumors may occur secondary to hyperparathyroidism in patients with chronic renal failure (ckd).
PubMedID- 25988877 The cost-effectiveness of drug therapies to treat secondary hyperparathyroidism in renal failure: a focus on evidence regarding paricalcitol and cinacalcet.
PubMedID- 24261327 Primary hyperparathyroidism with chronic renal failure in a vietnamese pot-bellied pig (sus scrofa).
PubMedID- 20800255 Background: in multiple endocrine neoplasia type i and renal failure, the type of initial parathyroidectomy for hyperparathyroidism may influence the operative risks and development of recurrence.
PubMedID- 24644527 In the third type, patients usually have a concurrent disease, such as chronic renal failure, with secondary hyperparathyroidism, hypervitaminosis d, milk-alkali syndrome, and bone destruction capable of causing soft-tissue calcification.
PubMedID- 26321566 The second patient had end-stage renal failure with tertiary hyperparathyroidism and was on haemodialysis.
PubMedID- 21168373 Vitamin d therapy is widely used for the treatment of hyperparathyroidism associated with chronic renal failure in renal disease patients.
PubMedID- 21112268 Surgical treatment of secondary hyperparathyroidism in patients with chronic renal failure.
PubMedID- 25886405 Hyperphosphatemia, hypocalcemia and hyperparathyroidism in children with chronic renal failure plays a significant role in bone disorders 1.
PubMedID- 21030332 The extensive myocardial calcification was secondary to hyperparathyroidism with renal failure.
PubMedID- 22984610 Calcitriol is an fda-approved drug commonly indicated in the management of secondary hyperparathyroidism in patients with renal failure, whereas astemizole was withdrawn from u.s. and european markets in 1999 after concerns about the drug's safety.
PubMedID- 22348675 Primary hyperparathyroidism as a cause of chronic renal failure.
PubMedID- 22009809 The diagnostic accuracy of high resolution ultrasound imaging for detection of secondary hyperparathyroidism in patients with chronic renal failure.
PubMedID- 22482374 Subjects on therapy like vitamin d and calcium supplements, corticosteroids or anti-epileptic medicines, primary hyperparathyroidism and hypercalcaemia, with co-morbidity like renal failure, liver disease and history of malabsorption, diarrhea or hyperthyroidism were excluded.
PubMedID- 23185261 Although transplantation can resolve many biochemical imbalances, such as hyperparathyroidism, associated with chronic renal failure, progressive loss of bmd in the trabecular bone often occurs early after renal transplantation 3.
PubMedID- 22101574 Secondary and tertiary hyperparathyroidism (hpt) develop in patients with renal failure due to a variety of mechanisms including increased phosphorus and fibroblast growth factor 23 (fgf23), and decreased calcium and 1,25-dihydroxy vitamin d levels.
PubMedID- 20844668 (3) secondary tumoral calcinosis: (chronic renal failure with secondary hyperparathyroidism, hypervitaminosis d, milk-alkali syndrome, and bone destruction).

Page: 1